A Molecular Revolution Is Underway in Thoracic Oncology - OncLive

Targetable alterations including BRAF V600E, EGFR exon 20 insertions, KRAS G12C mutations, MET exon 14 alterations, NTRK and RET rearrangements have taken up recent focus for investigators as data are pushing novel agents through the regulatory processes.

The fruits of decades of investigative efforts in thoracic oncology are ripe for picking, according to Solange Peters, MD, PhD. Targetable alterations including BRAF V600E, EGFR exon 20 insertions, K… [+16599 chars]

full article...